| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/08/2008 | CA2359354C Medicament for the treatment, prevention and diagnosis of infection due to chlamydia pneumoniae |
| 07/08/2008 | CA2342537C Modified e. coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein |
| 07/08/2008 | CA2308124C Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/08/2008 | CA2280770C Gene therapy for alleviating erectile dysfunction |
| 07/08/2008 | CA2250712C Chimeric isoprenoid synthases and uses thereof |
| 07/08/2008 | CA2221587C Promoters for gene expression |
| 07/08/2008 | CA2218111C Igf-i purification process |
| 07/08/2008 | CA2187444C Antirestenosis protein |
| 07/08/2008 | CA2187329C Pharmaceutical formulations for treating dust mite allergy |
| 07/08/2008 | CA2183406C Process for inactivating carboxypeptidase y in hirudin-containing culture broths |
| 07/08/2008 | CA2148907C Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/08/2008 | CA2132836C Immunization by inoculation of dna transcription unit |
| 07/08/2008 | CA1341576C Diagnosis of retinoblastoma |
| 07/03/2008 | WO2008080052A1 Transgenic mice expressing humanized vegf |
| 07/03/2008 | WO2008080045A2 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders |
| 07/03/2008 | WO2008080014A2 Antifungal plant proteins and methods of their use |
| 07/03/2008 | WO2008079849A2 Antibodies to insulin-like growth factor receptor |
| 07/03/2008 | WO2008079352A2 Antibodies to cd200r |
| 07/03/2008 | WO2008078198A2 Cells and methodology to generate non-segmented negative-strand rna viruses |
| 07/03/2008 | WO2008078177A2 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 07/03/2008 | WO2008078167A2 Consensus peptide |
| 07/03/2008 | WO2008077993A1 Novel peptides |
| 07/03/2008 | WO2008077616A1 Modified coagulation factors with prolonged in vivo half-life |
| 07/03/2008 | WO2008077527A1 Rsv f-protein and use thereof |
| 07/03/2008 | WO2008077521A1 Use of polypetides against diseases caused by protozoans |
| 07/03/2008 | WO2008077511A1 Human polyomavirus and methods of diagnosis and treatment |
| 07/03/2008 | WO2008077478A1 Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene |
| 07/03/2008 | WO2008077413A1 Dna vaccines for fish |
| 07/03/2008 | WO2008077397A2 Method and means for concentrating, removing, and detecting gram-positive bacteria |
| 07/03/2008 | WO2008077311A1 Hepatopoietin and use thereof |
| 07/03/2008 | WO2008077236A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | WO2008060702A3 Replikin peptides and uses thereof |
| 07/03/2008 | WO2008054592A9 Methods for production of recombinant plasminogen and plasmin polypeptides |
| 07/03/2008 | WO2008054592A2 Methods for production of recombinant plasminogen and plasmin polypeptides |
| 07/03/2008 | WO2008052501B1 Method of obtaining plant protein fractions with a medium molecular weight, plant protein fraction, and its use |
| 07/03/2008 | WO2008049920A3 Il-21 variants |
| 07/03/2008 | WO2008049225A8 Methods for diagnosing osteoarthritis |
| 07/03/2008 | WO2008046584A3 Lepa as a target for antibacterial agents |
| 07/03/2008 | WO2008036838A3 Isolated complexes of covalently cross-linked endotoxin and modified md-2 |
| 07/03/2008 | WO2008027944A3 Antigenic protein conjugates and process for preparing same |
| 07/03/2008 | WO2008027162A3 129xe biosensors and their use |
| 07/03/2008 | WO2008017863A3 Crystal structure of p53 mutants and their use |
| 07/03/2008 | WO2008017859A3 Ligand for the g6b receptor on blood platelets |
| 07/03/2008 | WO2008011586A3 Bacillus thuringiensis toxin with anti-coleopteran activity |
| 07/03/2008 | WO2007147165A3 Human cancer stem cell culture compositions comprising erbb2 variants and methods of use thereof |
| 07/03/2008 | WO2007131133A3 Methods and compositions relating to zpa polypeptides |
| 07/03/2008 | WO2007120542A3 Aav capsid library and aav capsid proteins |
| 07/03/2008 | WO2003068170A3 Enzyme treatment of foodstuffs for celiac sprue |
| 07/03/2008 | US20080163399 Axmi-008, a delta-endotoxin gene and methods for its use |
| 07/03/2008 | US20080163396 Plant genes encoding Dr1 and DRAP1, a global repressor complex of transcription |
| 07/03/2008 | US20080163393 Nucleotide sequences coding cinnamyl alcohol dehydrogenase (1) like (CAD1L) polypeptides for use modifying plant cell walls and/or defence response in plants |
| 07/03/2008 | US20080163392 Herbicide-tolerant plants through bypassing metabolic pathway |
| 07/03/2008 | US20080163387 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/03/2008 | US20080163386 Using transmembrane protein (CRB) gene sequences comprising rat insulin promoter (RIP1-Tag2) as diagnostic tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/03/2008 | US20080161917 Methods of making high-strength ndga polymerized collagen fibers and related collagen-prep methods, medical devices and constructs |
| 07/03/2008 | US20080161544 Chromatographic separation of therapeutic polypeptides |
| 07/03/2008 | US20080161543 Modified Clostridial Toxins With Altered Targeting Capabilities For Clostridial Toxin Target Cells |
| 07/03/2008 | US20080161540 IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| 07/03/2008 | US20080161539 Recombinant colony stimulating factor, erythropoietin, interferon and/or growth hormone cell stimulating factor (G-CSF) for use in treatment and prevention of viral and cell proliferative disorders |
| 07/03/2008 | US20080161537 Selective radiolabeling of biomolecules |
| 07/03/2008 | US20080161421 Tcell mediator/modulator assay based upon Tcell restricted transgenic mouse |
| 07/03/2008 | US20080161263 Fusion proteins of Mycobacterium tuberculosis |
| 07/03/2008 | US20080161259 Complementary to a target nucleotide sequence; reduces the expression and/or function of the target nucleotide sequence; antiinflammatory |
| 07/03/2008 | US20080161244 Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161239 Based on discovery that FBL2, a kind of F-box protein, which is a constituent of the SCF complex, binds to amyloid precursor protein (APP), and regulation of FBL2 expression influences the production of beta amyloid; SCF=(S-phase kinase-associated protein 1A (Skp1)-Cullin1-Ring box 1 (Rbx1) complex) |
| 07/03/2008 | US20080161238 Nucleic acid molecules encoding bacterial autoinducer inactivation proteins as targets for engineering disease resistance |
| 07/03/2008 | US20080161226 Activatable Clostridial Toxins |
| 07/03/2008 | US20080161203 Markers identified for liver fibrosis and cirrhosis and the microarray panel thereof |
| 07/03/2008 | US20080161191 Nucleic Acid Fragments Encoding Proteins Involved In Stress Response |
| 07/03/2008 | US20080160636 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same |
| 07/03/2008 | US20080160613 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/03/2008 | US20080160607 Dna construct encoding ce7-specific chimeric t cell receptor |
| 07/03/2008 | US20080160606 Expression vector comprising nucleotide sequences coding toxoplasma major surface antigen p30 for use in generation of immunoglobulin for use in prevention and treatment of parasitic infection |
| 07/03/2008 | US20080160595 Enzymatic polypeptide for use as diagnostic tool in screening parasiticides |
| 07/03/2008 | US20080160589 Nucleotide sequences coding respiratory chain system (RCS) and pyrroloquinoline quinone biosynthetic proteins for use in fermentation of vitamin c |
| 07/03/2008 | US20080160574 Chimeric coiled coil molecules |
| 07/03/2008 | US20080160570 Using escherichia as bioreactor for production of ubiquitin-somatotropin fusion protein for use in treatment of growth abnormalities |
| 07/03/2008 | US20080160546 Using tumor markers concentration as diagnostic indicators of cell proliferative disorders |
| 07/03/2008 | US20080160541 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
| 07/03/2008 | US20080160513 Characterization of Mcra Subunits and Uses Thereof |
| 07/03/2008 | US20080160507 Using cell-free protein synthesis mixture for use in translation and assembly of retroviral capsid and capsid intermediate particles |
| 07/03/2008 | US20080160048 Comprising chimeric cytomegalo virus related promoter sequence and cloning site for insertion of coding sequence in operable linkage; particle mediated gene therapy and immunization |
| 07/03/2008 | US20080160046 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
| 07/03/2008 | US20080160038 Non-anaphylactic Forms of Grass Pollen Ph1 p 6 Allergen and Their Use |
| 07/03/2008 | US20080160037 Novel beta-defensins |
| 07/03/2008 | US20080160033 Novel Screening Method |
| 07/03/2008 | US20080160026 Apo-2 ligand-anti-her-2 antibody synergism |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160021 Antagonist antibody or fragment that binds to a specific polypeptide, used for the treatment of a degenerative cartilaginous disorder, including osteo-, rheumatoid and psoriatic arthritis |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080160016 Compositions and methods of tolerizing a primate to an antigen |
| 07/03/2008 | US20080160002 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 07/03/2008 | US20080159993 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 07/03/2008 | US20080159986 Modulators of the functions of receptors of the tnf/ngf receptor family and other proteins |
| 07/03/2008 | US20080159985 Matrix material comprising electrodeposited biopolymers and/or pharmeceuticals for use in transfer and release of compounds into cells |
| 07/03/2008 | US20080159977 Modified, protease resistant, colony stimulating factor for use in treatment and prevention of autoimmune and cell proliferative diseases; directed protein evolution |
| 07/03/2008 | US20080159956 diagnosing and analyzing a mammal who has a risk of developing the disease, using antibody, or fragments thereof, which has a binding site specific for integrin |